Investigators evaluated the risk for hepatocellular carcinoma after direct-acting antivirals (DAA)-cured hepatitis C virus (HCV) in DAA-naive adults with HIV-HCV coinfection and advanced fibrosis.
Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.
The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.
The FDA approved perioperative durvalumab with FLOT chemotherapy for eligible patients with resectable Stage II-IVA gastric and GEJ cancers.
Olezarsen receives FDA Breakthrough Therapy status for adults with severe hypertriglyceridemia following positive results from CORE and CORE2 trials.
Intravenous anesthesia for painless gastroscopy among older adults is associated with lower postoperative cognitive dysfunction.
The World Health Organization's new strategic initiative focused on how to harness digital health technologies to improve health.
Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.
Children born to mothers with prepregnancy obesity face a higher risk for neurodevelopmental disorders (ie, epilepsy and intellectual disability).
The mean percent change in body weight from baseline to week 72 was −5.1%, −7.0%, and −9.6% with 6, 12, and 36 mg orforglipron vs −2.5% with placebo. HealthDay News — The oral small-molecule ...
The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, behavioral therapy.
A 4-week multimodal prehabilitation program before ESD improves postoperative functional recovery, muscle strength, and mental QOL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback